Laetitia Aymeric Selected Research

O-cyclopentyl-S-diethylaminoethyl methylphosphonothioate

3/2014

Cell-death-associated molecular patterns as determinants of cancer immunogenicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laetitia Aymeric Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 10/2009
2	Breast Neoplasms (Breast Cancer) 11/2014 - 10/2009
1	Atrophy 01/2022
1	Carcinogenesis 01/2022
1	Dysbiosis 01/2022
1	Necrosis 06/2012
1	Neoplasm Metastasis (Metastasis) 08/2011
1	Residual Neoplasm 06/2010

Drug/Important Bio-Agent (IBA)

6	AnthracyclinesIBA 11/2014 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 03/2014 - 10/2009
4	Adenosine Triphosphate (ATP)IBA 04/2013 - 10/2009
3	CytokinesIBA 03/2014 - 08/2011
2	InterferonsIBA 03/2014 - 03/2011
2	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 10/2009
2	InterleukinsIBA 06/2012 - 03/2011
2	Interleukin-18 (Interleukin 18)IBA 06/2012 - 08/2011
2	InflammasomesIBA 06/2012 - 10/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2011 - 02/2010
2	AntigensIBA 03/2011 - 10/2009
2	Interferon-gamma (Interferon, gamma)IBA 02/2010 - 10/2009
1	Propranolol (Inderal)FDA LinkGeneric 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Interferon Type IIBA 11/2014
1	Phosphates (Orthophosphate)IBA 03/2014
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Adenosine (Adenocard)FDA LinkGeneric 03/2014
1	Trastuzumab (Herceptin)FDA Link 03/2014
1	HMGB1 Protein (HMG1)IBA 03/2014
1	O-cyclopentyl-S-diethylaminoethyl methylphosphonothioateIBA 03/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014
1	CCR2 ReceptorsIBA 01/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2013
1	Antineoplastic Agents (Antineoplastics)IBA 06/2012
1	AntibodiesIBA 08/2011
1	Interleukin-17 (Interleukin 17)IBA 03/2011
1	Interleukin-22 (IL-22)IBA 03/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2011
1	Biological ProductsIBA 12/2010
1	Therapeutic UsesIBA 06/2010
1	Pharmaceutical PreparationsIBA 06/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2009
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2009
1	NLR ProteinsIBA 10/2009

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2014 - 10/2009
4	Therapeutics 01/2022 - 02/2010
2	Radiotherapy 03/2014 - 03/2011
1	Aftercare (After-Treatment) 03/2011